ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and patent office ruling in Germany in ResMed’s favor. A trial court ruling from the Munich District Court states that the headgear used on two Fisher & Paykel CPAP masks - the Simplus full face and Eson 2 nasal mask - infringes ResMed patent EP 2 373 368 B1 in Germany. In a separate decision, the Opposition Division of th...